Get started
Author

Benedetta Stefanini

Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma
2024 · Alessandro Vitale, Pierluigi Romano, et al. · JAMA Surgery · 52
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction
2024 · Claudia Angela Maria Fulgenzi, Bernhard Scheiner, et al. · JAMA Oncology · 47
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs
2023 · Nicola Reggidori, Laura Bucci, et al. · JHEP Reports · 20
PDF
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors
2022 · Benedetta Stefanini, Laura Bucci, et al. · Digestive and Liver Disease · 17
Surveillance for Hepatocellular Carcinoma in Patients with Successfully Treated Viral Disease of the Liver: A Systematic Review
2024 · Lorenzo Lani, Benedetta Stefanini, et al. · Liver Cancer · 14
Primary biliary cholangitis: current insights and novel therapies
2026 · Alessandro Granito, Georgios Pappas, et al. · Expert Review of Clinical Immunology · 9
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care
2024 · Benedetta Stefanini, Laura Bucci, et al. · Digestive and Liver Disease · 9
PDF
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab
2025 · Bernardo Stefanini, Fabio Piscaglia, et al. · Liver Cancer · 8
PDF
Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab
2025 · Andrea Dalbeni, Filippo Cattazzo, et al. · Scientific Reports · 5
PDF
Outcome of hepatic resection for HCC in ideal and non-ideal candidates
2025 · Lorenzo Lani, Laura Bucci, et al. · Hepatology Communications · 2
Feasibility of systemic anti-cancer therapy as an alternative to best supportive care in patients with advanced HCC and Child-Pugh B liver dysfunction
2023 · Claudia Fulgenzi, Antonio D’Alessio, et al. · Journal of Hepatology · 1
THU-472-YI Sorafenib as a second-line treatment after failure of Atezolizumab/Bevacizumab
2024 · Francesco Tovoli, Maria Boe, et al. · Journal of Hepatology
THU-481-YI Hepatic resection in patients with hepatocellular carcinoma: the message coming from real world data
2024 · Lorenzo Lani, Laura Bucci, et al. · Journal of Hepatology
SAT-477-YI The impact of etiologyon patterns of progression of advanced HCC
2024 · Bernardo Stefanini, Fabio Piscaglia, et al. · Journal of Hepatology
Potential faesability of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma: a real-world analysis
2022 · Benedetta Stefanini, Laura Bucci, et al. · Journal of Hepatology
Validation of the prognostic role of a new distinct assessment of liver function in non surgical HCC patients
2022 · Bernardo Stefanini, Benedetta Stefanini, et al. · Journal of Hepatology
Works count: 16
Citation count: 184
H-index: 8
I10-index: 5
Year
Topic
Type